Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales: Ruperto, N, Lovell, DJ, Reiff, A, Gamir, M, Higgins, G, Koné-Paut, I, Jones, OY, Chalom, E, Ilowite, N, Wouters, C, McIlraith, MJ, Liu, S, Kupper, H, Giannini, EH, Martini, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194421/
http://dx.doi.org/10.1186/1546-0096-9-S1-O26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194421/
http://dx.doi.org/10.1186/1546-0096-9-S1-O26

Ejemplares similares